Search

Your search keyword '"Mahon, Barbara E."' showing total 433 results
Start Over Author "Mahon, Barbara E."
433 results on '"Mahon, Barbara E."'

2. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016–2022

Author

McMorrow, Meredith L., primary, Moline, Heidi L., additional, Toepfer, Ariana P., additional, Halasa, Natasha B., additional, Schuster, Jennifer E., additional, Staat, Mary A., additional, Williams, John V., additional, Klein, Eileen J., additional, Weinberg, Geoffrey A., additional, Clopper, Benjamin R., additional, Boom, Julie A., additional, Stewart, Laura S., additional, Selvarangan, Rangaraj, additional, Schlaudecker, Elizabeth P., additional, Michaels, Marian G., additional, Englund, Janet A., additional, Albertin, Christina S., additional, Mahon, Barbara E., additional, Hall, Aron J., additional, Sahni, Leila C., additional, and Curns, Aaron T., additional

Published
2024
Full Text
View/download PDF

3. Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86--Worldwide, July-October 2023

Author

Lambrou, Anastasia S., South, Erin, Ballou, Eliza S., Paden, Clinton R., Fuller, James A., Bart, Stephen M., Butryn, Deena M., Novak, Ryan T., Browning, Sean D., Kirby, Amy E., Welsh, Rory M., Cornforth, Daniel M., MacCannell, Duncan R., Friedman, Cindy R., Thornburg, Natalie J., Hall, Aron J., Hughes, Laura J., Mahon, Barbara E., Daskalakis, Demetre C., Shah, Nirav D., Jackson, Brendan R., and Kirking, Hannah L.

Subjects
Wastewater -- Health aspects, Risk assessment -- Health aspects, Travelers -- Health aspects, Public health -- Health aspects, Health
Abstract

Introduction CDC uses a diverse, multicomponent surveillance approach to track the emergence of new and potentially significant SARS-CoV-2 variants across the United States and globally. These surveillance systems include genomic, [...]

Published
2023

4. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged [greater than or equal to] 6 Months: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2023

Author

Regan, Joanna J., Moulia, Danielle L., Link-Gelles, Ruth, Godfrey, Monica, Mak, Josephine, Najdowski, Morgan, Rosenblum, Hannah G., Shah, Melisa M., Twentyman, Evelyn, Meyer, Sarah, Peacock, Georgina, Thornburg, Natalie, Havers, Fiona P., Saydah, Sharon, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Mahon, Barbara E., Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination -- Usage, RNA -- Usage, Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On October 10, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction By the end of 2022, COVID-19 vaccines had prevented 18.5 million [...]

Published
2023

5. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices--United States, 2023

Author

Fleming-Dutra, Katherine E., Jones, Jefferson M., Roper, Lauren E., Prill, Mila M., Ortega-Sanchez, Ismael R., Moulia, Danielle L., Wallace, Megan, Godfrey, Monica, Broder, Karen R., Tepper, Naomi K., Brooks, Oliver, Sanchez, Pablo J., Kotton, Camille N., Mahon, Barbara E., Long, Sarah S., and McMorrow, Meredith L.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Vaccination -- Usage, Diseases -- Prevention -- United States -- France -- United Kingdom, Infants -- Usage, Drug approval -- Usage, Epidemiology -- Usage, Vaccines -- Usage, Pregnant women -- Usage, Pharmaceutical industry -- Usage, Health, Abrysvo (Vaccine) -- Usage
Abstract

On October 6, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction In August 2023, the Food and Drug Administration (FDA) approved RSVpreF [...]

Published
2023

6. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine

Author

Wong, Karen K, Burdette, Erin, Mahon, Barbara E, Mintz, Eric D, Ryan, Edward T, and Reingold, Arthur L

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Biodefense, Emerging Infectious Diseases, Vaccine Related, Rare Diseases, Immunization, Prevention, Foodborne Illness, Biotechnology, Infectious Diseases, Digestive Diseases, Infection, Good Health and Well Being, Adolescent, Adult, Advisory Committees, Centers for Disease Control and Prevention, U.S., Cholera, Cholera Vaccines, Humans, Middle Aged, Travel, United States, Young Adult, General & Internal Medicine
Abstract

Cholera, caused by infection with toxigenic Vibrio cholerae bacteria of serogroup O1 (>99% of global cases) or O139, is characterized by watery diarrhea that can be severe and rapidly fatal without prompt rehydration. Cholera is endemic in approximately 60 countries and causes epidemics as well. Globally, cholera results in an estimated 2.9 million cases of disease and 95,000 deaths annually (1). Cholera is rare in the United States, and most U.S. cases occur among travelers to countries where cholera is endemic or epidemic. Forty-two U.S. cases were reported in 2011 after a cholera epidemic began in Haiti (2); however,

Published
2017

8. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022.

Author

McMorrow, Meredith L., Moline, Heidi L., Toepfer, Ariana P., Halasa, Natasha B., Schuster, Jennifer E., Staat, Mary A., Williams, John V., Klein, Eileen J., Weinberg, Geoffrey A., Clopper, Benjamin R., Boom, Julie A., Stewart, Laura S., Selvarangan, Rangaraj, Schlaudecker, Elizabeth P., Michaels, Marian G., Englund, Janet A., Albertin, Christina S., Mahon, Barbara E., Hall, Aron J., and Sahni, Leila C.

Published
2024
Full Text
View/download PDF

9. Pregnancy Outcomes among Women Receiving rVSV[DELTA]-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Author

Legardy-Williams, Jennifer K., Carter, Rosalind J., Goldstein, Susan T., Jarrett, Olamide D., Szefer, Elena, Fombah, Augustin E., Tinker, Sarah C., Samai, Mohamed, and Mahon, Barbara E.

Subjects
Ebola hemorrhagic fever -- Prevention, Pregnancy complications -- Risk factors, Medical research, Ebola vaccines -- Complications and side effects, Vaccines, Virus diseases, Genetic disorders, Infants, Clinical trials, Pregnant women, Vaccination, Viremia, Health
Abstract

The 2014-2016 West Africa Ebola virus disease outbreak was unprecedented in magnitude and complexity, resulting in >28,000 cases and >11,000 deaths in the 3 highly affected countries (Sierra Leone, Guinea, [...]

Published
2020
Full Text
View/download PDF

10. COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration--United States, May 11, 2023

Author

Silk, Benjamin J., Scobie, Heather M., Duck, William M., Palmer, Tess, Ahmad, Farida B., Binder, Alison M., Cisewski, Jodi A., Kroop, Seth, Soetebier, Karl, Park, Meeyoung, Kite-Powell, Aaron, Cool, Andrea, Connelly, Erin, Dietz, Stephanie, Kirby, Amy E., Hartnett, Kathleen, Johnston, Jocelyn, Khan, Diba, Stokley, Shannon, Paden, Clinton R., Sheppard, Michael, Sutton, Paul, Razzaghi, Hilda, Anderson, Robert N., Thornburg, Natalie, Meyer, Sarah, Womack, Caryn, Weakland, Aliki P., McMorrow, Meredith, Broeker, Lanson R., Winn, Amber, Hall, Aron J., Jackson, Brendan, Mahon, Barbara E., and Ritchey, Matthew D.

Subjects
United States. Department of Health and Human Services, Public health -- Health aspects, Health
Abstract

On May 5, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). On January 31, 2020, the U.S. Department of Health and Human Services [...]

Published
2023

11. Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

Author

Regan, Joanna J., primary, Moulia, Danielle L., additional, Link-Gelles, Ruth, additional, Godfrey, Monica, additional, Mak, Josephine, additional, Najdowski, Morgan, additional, Rosenblum, Hannah G., additional, Shah, Melisa M., additional, Twentyman, Evelyn, additional, Meyer, Sarah, additional, Peacock, Georgina, additional, Thornburg, Natalie, additional, Havers, Fiona P., additional, Saydah, Sharon, additional, Brooks, Oliver, additional, Talbot, H. Keipp, additional, Lee, Grace M., additional, Bell, Beth P., additional, Mahon, Barbara E., additional, Daley, Matthew F., additional, Fleming-Dutra, Katherine E., additional, and Wallace, Megan, additional

Published
2023
Full Text
View/download PDF

13. The Sierra Leone Trial to Introduce a Vaccine Against Ebola : An Evaluation of rVSVΔG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

Author

STRIVE Study Team, Samai, Mohamed, Seward, Jane F., Goldstein, Susan T., Mahon, Barbara E., Lisk, Durodami Radcliffe, Widdowson, Marc-Alain, Jalloh, Mohamed I., Schrag, Stephanie J., Idriss, Ayesha, Carter, Rosalind J., Dawson, Peter, Kargbo, S. A. S., Leigh, Bailah, Bawoh, Mohamed, Legardy-Williams, Jennifer, Deen, Gibrilla, Carr, Wendy, Callis, Amy, Lindblad, Robert, Russell, James B. W., Petrie, Carey R., Fombah, Augustin E., Kargbo, Brima, McDonald, Wendi, Jarrett, Olamide D., Walker, Robert E., Gargiullo, Paul, Bash-Taqi, Donald, Gibson, Laura, Fofanah, Abu Bakarr, and Schuchat, Anne

Published
2018

14. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic : The Sierra Leone Trial to Introduce a Vaccine Against Ebola

Author

Conteh, Muhammad-Abbas, Goldstein, Susan T., Wurie, Haja R., Gidudu, Jane, Lisk, Durodami Radcliffe, Carter, Rosalind J., Seward, Jane F., Hampton, Lee M., Wang, David, Andersen, Lauren E., Arvay, Melissa, Schrag, Stephanie J., Dawson, Peter, Fombah, Augustin E., Petrie, Carey R., Feikin, Daniel R., Russell, James B. W., Lindblad, Robert, Kargbo, S. A. S., Samai, Mohamed, and Mahon, Barbara E.

Published
2018

16. Health Conditions in an Adult Population in Sierra Leone : Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

Author

Fombah, Augustin E., Goldstein, Susan T., Jarrett, Olamide D., Jalloh, Mohamed I., El-Khorazaty, Jill, Lisk, Durodami Radcliffe, Legardy-Williams, Jennifer, Pratt, Dudley A., George, Peter M., Russell, James B. W., Schrag, Stephanie J., Dawson, Peter, Deen, Gibrilla F., Carr, Wendy, Lindblad, Robert, James, Faustine, Bah, Mohamed M., Yillia, John F., Sandy, Jibao D., Turay, Patrick E., Conteh, Muhammad-Abbas, Slutsker, Laurence, Mahon, Barbara E., Samai, Mohamed, and Seward, Jane F.

Published
2018

18. Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt—Liberia, 2017: an epidemiological and laboratory investigation

Author

Konway, Youhn, Wiah, Samson Q, Doedeh, Vivian, Bao, Umaru, Senneh, George, Gorwor, Lawrence, Gonotee, Philemon, Paasewe, Thomas, Tamatai, George, Yarkeh, James, Smith, Samuel, Brima-Davis, Annette, Dauda, George, Monger, Thomas, Gornor-Pewu, Leleh W, Lombeh, Siafa, Wilson, Himiede W, Korvayan, Mark, Dovillie, Nathaniel, Jetoh, Ralph, Taweh, Fahn, Vera Walker, Yatta, Hardy, Patrick, Freeman, Maxwell, George, Geraldine, Kerwillain, Garrison, Toe, Sylvester, Ghartey, Emmanuel, Larway, Lawrence, Gweh, Dedesco, Allen, Denise, Friesen, Suzanne, Gwesa, Gulu, Kinkade, Carl, Reed, Mulbah, Chang, Arthur, George, Josiah, Schier, Joshua, Thomas, Jerry, Diaz, Maureen H, Jenkins, Laurel T, Mahon, Barbara E, Schmink, Susanna E, Joseph, Sandeep J, Waller, Jessica L, Whaley, Melissa J, Winchell, Jonas M, Arthur, Ray R, Fuller, Serena, Christian, Kira, Redd, John T, Yealue, Kwuakuan D M, II, Naiene, Jeremias, Asamoah Frimpong, Joseph, Amo-Addae, Maame, Stephen, Olayinka, Von Gottberg, Anne, Taha, Muhamed, Bozio, Catherine H, Vuong, Jeni, Dokubo, E Kainne, Fallah, Mosoka P, McNamara, Lucy A, Potts, Caelin C, Doedeh, John, Gbanya, Miatta, Retchless, Adam C, Patel, Jaymin C, Clark, Thomas A, Kohar, Henry, Nagbe, Thomas, Clement, Peter, Katawera, Victoria, Mahmoud, Nuha, Djingarey, Harouna M, Perrocheau, Anne, Naidoo, Dhamari, Stone, Mardia, George, Roseline N, Williams, Desmond, Gasasira, Alex, Nyenswah, Tolbert, Wang, Xin, and Fox, LeAnne M

Published
2018
Full Text
View/download PDF

21. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Author

Jones, Jefferson M., primary, Fleming-Dutra, Katherine E., additional, Prill, Mila M., additional, Roper, Lauren E., additional, Brooks, Oliver, additional, Sánchez, Pablo J., additional, Kotton, Camille N., additional, Mahon, Barbara E., additional, Meyer, Sarah, additional, Long, Sarah S., additional, and McMorrow, Meredith L., additional

Published
2023
Full Text
View/download PDF

22. Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems--United States, August 2022

Author

Massetti, Greta M., Jackson, Brendan R., Brooks, John T., Perrine, Cria G., Reott, Erica, Hall, Aron J., Lubar, Debra, Williams, Ian T., Ritchey, Matthew D., Patel, Pragna, Liburd, Leandris C., and Mahon, Barbara E.

Subjects
United States. Department of Health and Human Services, Infection -- Care and treatment -- Prevention, Public health -- Health aspects -- Social aspects, Vaccines -- Health aspects -- Social aspects, Health
Abstract

On August 11, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). As SARS-CoV-2, the virus that causes COVID-19, continues to circulate globally, high [...]

Published
2022

24. Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability--United States, December 23, 2021-May 21, 2022

Author

Gold, Jeremy A.W, Kelleher, James, Magid, Jake, Jackson, Brendan R., Pennini, Meghan E., Kushner, Diana, Weston, Emily J., Rasulnia, Bobby, Kuwabara, Sachiko, Bennett, Kelly, Mahon, Barbara E., Patel, Anita, and Auerbach, John

Subjects
United States. Food and Drug Administration -- Reports, United States. Census Bureau -- Reports, United States. Department of Health and Human Services -- Reports, Antiviral agents -- Health aspects -- Reports, Health, Lagevrio (Medication) -- Reports -- Health aspects, Paxlovid (Medication) -- Reports -- Health aspects
Abstract

On June 21, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The COVID-19 pandemic has highlighted and exacerbated long-standing inequities in the social [...]

Published
2022

25. Estimated incidence of antimicrobial drug-resistant nontyphoidal Salmonella infections, United States, 2004-2012

Author

Medalla, Felicita, Gu, Weidong, Mahon, Barbara E., Judd, Michael, Folster, Jason, Griffin, Patricia M., and Hoekstra, Robert M.

Subjects
United States. Centers for Disease Control and Prevention -- Analysis, Salmonellosis -- Analysis -- Health aspects, Salmonella -- Analysis -- Health aspects, Ampicillin -- Contamination -- Analysis -- Health aspects, Microbial drug resistance -- Analysis -- Health aspects, Medical research -- Analysis -- Health aspects, Infection -- Analysis -- Health aspects, Ciprofloxacin -- Contamination -- Analysis -- Health aspects, Health
Abstract

Each year in the United States, nontyphoidal Salmonella causes an estimated 1.2 million illnesses, 23,000 hospitalizations, and 450 deaths (1). Antimicrobial drug-resistant Salmonella is a serious threat to public health [...]

Published
2017

28. Large Outbreak of Botulism Associated with a Church Potluck Meal — Ohio, 2015

Author

McCarty, Carolyn L., Angelo, Kristina, Beer, Karlyn D., Cibulskas-White, Katie, Quinn, Kim, de Fijter, Sietske, Bokanyi, Rick, St.Germain, Eric, Baransi, Karen, Barlow, Kevin, Shafer, Gwen, Hanna, Larry, Spindler, Kelly, Walz, Elizabeth, DiOrio, Mary, Jackson, Brendan R., Luquez, Carolina, Mahon, Barbara E., Basler, Colin, Curran, Kathryn, Matanock, Almea, Walsh, Kelly, Slifka, Kara Jacobs, and Rao, Agam K.

Published
2015

29. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years--United States, March 1, 2020-June 28, 2021

Author

Barrett, Catherine E., Koyama, Alain K., Alvarez, Pablo, Chow, Wilson, Lundeen, Elizabeth A., Perrine, Cria G., Pavkov, Meda E., Rolka, Deborah B., Wiltz, Jennifer L., Bull-Otterson, Lara, Gray, Simone, Boehmer, Tegan K., Gundlapalli, Adi V., Siegel, David A., Kompaniyets, Lyudmyla, Goodman, Alyson B., Mahon, Barbara E., Tauxe, Robert V., Remley, Karen, and Saydah, Sharon

Subjects
Infection -- Risk factors, Type 2 diabetes -- Risk factors, Diabetics, Health
Abstract

On January 7, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The COVID-19 pandemic has disproportionately affected people with diabetes, who are at [...]

Published
2022

31. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Author

Simon, Jakub K., primary, Kennedy, Stephen B., additional, Mahon, Barbara E., additional, Dubey, Sheri A., additional, Grant-Klein, Rebecca J., additional, Liu, Ken, additional, Hartzel, Jonathan, additional, Coller, Beth-Ann G., additional, Welebob, Carolee, additional, Hanson, Mary E., additional, and Grais, Rebecca F., additional

Published
2022
Full Text
View/download PDF

36. Invasive Listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004—2009: Further Targeted Prevention Needed for Higher-Risk Groups

Author

Silk, Benjamin J., Date, Kashmira A., Jackson, Kelly A., Pouillot, Régis, Holt, Kristin G., Graves, Lewis M., Ong, Kanyin L., Hurd, Sharon, Meyer, Rebecca, Marcus, Ruthanne, Shiferaw, Beletshachew, Norton, Dawn M., Medus, Carlota, Zansky, Shelley M., Cronquist, Alicia B., Henao, Olga L., Jones, Timothy F., Vugia, Duc J., Farley, Monica M., and Mahon, Barbara E.

Published
2012
Full Text
View/download PDF

44. Incidence of Cronobacter spp. infections, United States, 2003-2009

Author

Patrick, Mary E., Mahon, Barbara E., Greene, Sharon A., Rounds, Joshua, Cronquist, Alicia, Wymore, Katie, Boothe, Effie, Lathrop, Sarah, Palmer, Amanda, and Bowen, Anna

Subjects
Enterobacteriaceae infections -- Risk factors, Children -- Health aspects, Health
Abstract

Cronobacter spp. are gram-negative bacteria mainly perceived to cause serious infections in infants (1). Cases are most common among newborns or young infants; estimated mortality rates are as high as [...]

Published
2014
Full Text
View/download PDF

46. Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States

Author

Chung, Wendy M., Smith, Jessica C., Weil, Lauren M., Hughes, Sonya M., Joyner, Sibeso N., Hall, Emily M., Ritch, Julia, Srinath, Divya, Goodman, Edward, Chevalier, Michelle S., Epstein, Lauren, Hunter, Jennifer C., Kallen, Alexander J., Karwowski, Mateusz P., Kuhar, David T., Smith, Charnetta, Petersen, Lyle R., Mahon, Barbara E., Lakey, David L., and Schrag, Stephanie J.

Published
2015

48. Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein: Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

Author

Mahon, Barbara E, Simon, Jakub, Widdowson, Marc-Alain, Samai, Mohamed, Rogier, Eric, Legardy-Williams, Jennifer, Liu, Kenneth, Schiffer, Jarad, Lange, James, DeByle, Carolynn, Pinner, Robert, Schuchat, Anne, Slutsker, Laurence, and Goldstein, Susan

Subjects
Adult, Male, Adolescent, Enzyme-Linked Immunosorbent Assay, Hemorrhagic Fever, Ebola, Middle Aged, Antibodies, Viral, Ebolavirus, Parasitemia, Recombinant Proteins, Malaria, Sierra Leone, Major Articles and Brief Reports, Immunogenicity, Vaccine, Viral Envelope Proteins, parasitic diseases, Animals, Humans, Female, Ebola Vaccines, Vesicular Stomatitis, Asymptomatic Infections, Aged
Abstract

BACKGROUND: The effect of malaria infection on the immunogenicity of the recombinant vesicular stomatitis virus–Zaire Ebola virus envelope glycoprotein (GP) vaccine (rVSVΔG-ZEBOV-GP) (ERVEBO) is unknown. METHODS: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) vaccinated 7998 asymptomatic adults with rVSVΔG-ZEBOV-GP during the 2014–2016 Ebola epidemic. In STRIVE’s immunogenicity substudy, participants provided blood samples at baseline and at 1, 6, and 9–12 months. Anti-GP binding and neutralizing antibodies were measured using validated assays. Baseline samples were tested for malaria parasites by polymerase chain reaction. RESULTS: Overall, 506 participants enrolled in the immunogenicity substudy and had ≥1 postvaccination antibody titer. Of 499 participants with a result, baseline malaria parasitemia was detected in 73 (14.6%). All GP enzyme-linked immunosorbent assay (ELISA) and plaque reduction neutralization test (PRNT) geometric mean titers (GMTs) at 1, 6, and 9–12 months were above baseline, and 94.1% of participants showed seroresponse by GP-ELISA (≥2-fold rise and ≥200 ELISA units/mL), while 81.5% showed seroresponse by PRNT (≥4-fold rise) at ≥1 postvaccination assessment. In participants with baseline malaria parasitemia, the PRNT seroresponse proportion was lower, while PRNT GMTs and GP-ELISA seroresponse and GMTs showed a trend toward lower responses at 6 and 9–12 months. CONCLUSION: Asymptomatic adults with or without malaria parasitemia had robust immune responses to rVSVΔG-ZEBOV-GP, persisting for 9–12 months. Responses in those with malaria parasitemia were somewhat lower.

Published
2021

50. Nonpasteurized dairy products, disease outbreaks, and state laws--United States, 1993-2006

Author

Langer, Adam J., Ayers, Tracy, Grass, Julian, Lynch, Michael, Angulo, Frederick J., and Mahon, Barbara E.

Subjects
United States. Centers for Disease Control and Prevention, Children -- Diseases, Health surveys -- Health aspects, Continuing medical education -- Health aspects, Food poisoning -- Health aspects, Dairy industry -- Health aspects, Consumer education -- Health aspects, Public health -- Health aspects, Disease transmission -- Health aspects, Online health care information services -- Health aspects, Food contamination -- Health aspects, Basalt -- Health aspects, Online health care service, Health
Abstract

In the United States, milk and other dairy products are dietary staples; the 2010 Dietary Guidelines for Americans recommend that most Americans include dairy products in their diet (1). However, [...]

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results